

"AI powered skin cancer detection integrated into NHS dermatology pathways"
Skin Analytics develops DERM, an AI as a Medical Device for autonomous clinical decisions in dermatology. The teledermatology platform triages skin lesions by ruling out melanoma with 99.9% accuracy, enabling discharge of patients with non cancerous lesions without specialist appointments. It addresses NHS capacity constraints where cancer referrals grow 10% yearly while one in four dermatologist posts remain unfilled. Deployed across 25 NHS organisations since 2020, DERM has enabled over 150,000 assessments. It reduces urgent referrals by up to 20% in primary care and avoids 55 to 65% of appointments, directing dermatologist capacity toward patients who need it most while delivering sustainable pathways.


94
Team Members
2012
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where no one dies from skin cancer because AI enables universal access to dermatologist quality assessments, removing capacity barriers and ensuring every suspicious lesion receives timely, accurate clinical evaluation.
Empowers health systems to dramatically improve access to dermatologist quality skin cancer assessments while reducing the financial burden through AI enabled patient pathways that deliver better outcomes sustainably.